General InformationEli Lilly and Company is a publicly traded pharmaceutical giant headquartered in Indianapolis, Indiana, with over 40,000 employees worldwide, founded in 1876.
Funding & FinancialsAs a public company trading on NYSE (LLY), Eli Lilly has a market capitalization exceeding $800 billion as of 2024 and generates annual revenue of over $34 billion.
Leadership & TeamCEO David A. Ricks has led the company since 2017 and is focused on expanding the company's pipeline in diabetes, obesity, and oncology therapeutics.
Recent ActivityEli Lilly has seen rapid growth from its Mounjaro (tirzepatide) obesity and diabetes franchise, with the company also pursuing phase 3 trials for orforglipron (oral GLP-1 agonist) and expanding investments in AI-powered drug discovery capabilities in 2024.